Suppr超能文献

普罗帕酮在中国受试者中的立体选择性稳态处置及作用

Stereoselective steady state disposition and action of propafenone in Chinese subjects.

作者信息

Li G, Gong P L, Qiu J, Zeng F D, Klotz U

机构信息

Department of Clinical Pharmacology, School of Pharmacy, Tongji Medical University, Wuhan/PR China.

出版信息

Br J Clin Pharmacol. 1998 Nov;46(5):441-5. doi: 10.1046/j.1365-2125.1998.00806.x.

Abstract

AIMS

To investigate the steady state disposition and action of racemic propafenone and its enantiomers and the potential for an enantiomer-enantiomer interaction in Chinese subjects.

METHODS

Eight healthy male Chinese individuals received in a double-blind, randomized, cross-over study racemic propafenone (150 mg every 6 h), (S)-, and (R)-propafenone (150 mg each every 6 h) and placebo orally for 4 days. During the last dosing interval the plasma concentrations of both enantiomers of propafenone were measured and ECG, blood pressure (MAP) and heart rate were monitored.

RESULTS

Whereas the apparent elimination half-life (t1/2,z), mean residence time (MRT) and time to reach peak concentrations (tmax) of (S)- and (R)-propafenone were similar and independent of the administered agent, significant differences were observed in the apparent oral clearance (CLO) of the enantiomers. During dosing with racemic propafenone CLO of (S)- and (R)-propafenone averaged (+/-s.d.) 1226+751 and 1678+625 ml min(-1), respectively (P=0.024). Following the administration of the pure enantiomers CLO of (S)-propafenone increased (P= 0.007) to 2028+/-959 ml min(-1) and that of (R)-propafenone was reduced (P= 0.042) to 1318+/-867 ml min(-1). Both enantiomers and the racemate caused about a 10% increase in the QRS duration (P<0.05) and PR-interval (P<0.01) when compared with placebo. The increase in maximum exercise heart rate was significantly (P<0.05) attenuated only at 3 h following the administration of the racemate and the S-enantiomer. MAP and QTC were not affected significantly.

CONCLUSIONS

These data indicate that the stereoselective disposition of propafenone is similar in Chinese and Caucasian subjects (previously published findings), the (R)-enantiomer being cleared more rapidly. A similar enantiomer-enantiomer interaction also occurred. Thus, when the racemate was given, the elimination of (S)-propafenone was impaired and that of the (R)-form accelerated compared with single enantiomer administration. The results indicate that dosage adjustments are probably not required in Chinese patients receiving propafenone.

摘要

目的

研究消旋普罗帕酮及其对映体在中国受试者中的稳态处置、作用以及对映体间相互作用的可能性。

方法

8名健康中国男性个体参与一项双盲、随机、交叉研究,口服消旋普罗帕酮(每6小时150毫克)、(S)-普罗帕酮和(R)-普罗帕酮(各每6小时150毫克)以及安慰剂,持续4天。在最后一个给药间隔期间,测定普罗帕酮两种对映体的血浆浓度,并监测心电图、血压(平均动脉压)和心率。

结果

(S)-和(R)-普罗帕酮的表观消除半衰期(t1/2,z)、平均驻留时间(MRT)以及达峰浓度时间(tmax)相似,且与给药制剂无关,但对映体的表观口服清除率(CLO)存在显著差异。在给予消旋普罗帕酮期间,(S)-和(R)-普罗帕酮的CLO平均值(±标准差)分别为1226±751和1678±625毫升/分钟(P = 0.024)。给予纯对映体后,(S)-普罗帕酮的CLO增加(P = 0.007)至2028±959毫升/分钟,而(R)-普罗帕酮的CLO降低(P = 0.042)至1318±867毫升/分钟。与安慰剂相比,两种对映体以及消旋体均使QRS时限(P < 0.05)和PR间期(P < 0.01)增加约10%。仅在给予消旋体和S-对映体后3小时,最大运动心率的增加显著(P < 0.05)减弱。平均动脉压和QTc未受到显著影响。

结论

这些数据表明,普罗帕酮的立体选择性处置在中国人和高加索人受试者中相似(先前已发表的研究结果),(R)-对映体清除更快。类似的对映体间相互作用也会发生。因此,给予消旋体时,与单一对映体给药相比,(S)-普罗帕酮的消除受损,而(R)-形式的消除加速。结果表明,接受普罗帕酮治疗的中国患者可能无需调整剂量。

相似文献

1
Stereoselective steady state disposition and action of propafenone in Chinese subjects.
Br J Clin Pharmacol. 1998 Nov;46(5):441-5. doi: 10.1046/j.1365-2125.1998.00806.x.
2
Fluoxetine impairs the CYP2D6-mediated metabolism of propafenone enantiomers in healthy Chinese volunteers.
Clin Pharmacol Ther. 1999 Nov;66(5):516-21. doi: 10.1016/S0009-9236(99)70015-9.
4
Stereoselective pharmacokinetics of propafenone and its major metabolites in healthy Chinese volunteers.
Eur J Pharm Sci. 2000 Mar;10(1):11-6. doi: 10.1016/s0928-0987(99)00083-4.
6
Stereoselective disposition and pharmacologic activity of propafenone enantiomers.
Circulation. 1989 May;79(5):1068-76. doi: 10.1161/01.cir.79.5.1068.
7
The influence of CYP2D6 activity on the kinetics of propafenone enantiomers in Chinese subjects.
Br J Clin Pharmacol. 1999 May;47(5):553-6. doi: 10.1046/j.1365-2125.1999.00932.x.
10
Pharmacokinetic and pharmacodynamic interaction between mexiletine and propafenone in human beings.
Clin Pharmacol Ther. 2000 Jul;68(1):44-57. doi: 10.1067/mcp.2000.108023.

引用本文的文献

1
A Tissue Distribution Study of Propafenone in an Intentional Fatal Poisoning Case.
Int J Mol Sci. 2024 May 10;25(10):5202. doi: 10.3390/ijms25105202.
2
The Effect of CYP2D6 Phenotypes on the Pharmacokinetics of Propafenone: A Systematic Review and Meta-Analysis.
Pharmaceutics. 2022 Jul 11;14(7):1446. doi: 10.3390/pharmaceutics14071446.
3
Impact of stereoselectivity on the pharmacokinetics and pharmacodynamics of antiarrhythmic drugs.
Clin Pharmacokinet. 2002;41(8):533-58. doi: 10.2165/00003088-200241080-00001.

本文引用的文献

2
Propafenone-theophylline interaction.
Pharmacotherapy. 1993 Jan-Feb;13(1):68-71.
4
Ethnic differences in response to morphine.
Clin Pharmacol Ther. 1993 Nov;54(5):507-13. doi: 10.1038/clpt.1993.182.
7
Propafenone disposition kinetics in cardiac arrhythmia.
Clin Pharmacol Ther. 1984 Aug;36(2):163-8. doi: 10.1038/clpt.1984.157.
9
Pharmacokinetics and pharmacodynamics of propafenone during acute and chronic administration.
Eur J Clin Pharmacol. 1988;34(2):187-94. doi: 10.1007/BF00614557.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验